PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
VRTX vs. REGN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between VRTX and REGN is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.4

Performance

VRTX vs. REGN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vertex Pharmaceuticals Incorporated (VRTX) and Regeneron Pharmaceuticals, Inc. (REGN). The values are adjusted to include any dividend payments, if applicable.

2,000.00%4,000.00%6,000.00%8,000.00%10,000.00%12,000.00%JulyAugustSeptemberOctoberNovemberDecember
2,386.11%
6,871.90%
VRTX
REGN

Key characteristics

Sharpe Ratio

VRTX:

0.49

REGN:

-0.73

Sortino Ratio

VRTX:

0.79

REGN:

-0.86

Omega Ratio

VRTX:

1.10

REGN:

0.89

Calmar Ratio

VRTX:

0.79

REGN:

-0.40

Martin Ratio

VRTX:

1.67

REGN:

-1.10

Ulcer Index

VRTX:

6.34%

REGN:

14.62%

Daily Std Dev

VRTX:

21.50%

REGN:

21.90%

Max Drawdown

VRTX:

-91.77%

REGN:

-91.81%

Current Drawdown

VRTX:

-13.40%

REGN:

-40.54%

Fundamentals

Market Cap

VRTX:

$120.84B

REGN:

$81.32B

EPS

VRTX:

-$1.88

REGN:

$40.40

PEG Ratio

VRTX:

1.23

REGN:

1.10

Total Revenue (TTM)

VRTX:

$10.61B

REGN:

$13.85B

Gross Profit (TTM)

VRTX:

$9.14B

REGN:

$11.69B

EBITDA (TTM)

VRTX:

$517.70M

REGN:

$4.83B

Returns By Period

In the year-to-date period, VRTX achieves a 9.98% return, which is significantly higher than REGN's -18.64% return. Over the past 10 years, VRTX has outperformed REGN with an annualized return of 14.21%, while REGN has yielded a comparatively lower 5.28% annualized return.


VRTX

YTD

9.98%

1M

-4.18%

6M

-4.23%

1Y

11.00%

5Y*

15.24%

10Y*

14.21%

REGN

YTD

-18.64%

1M

-6.22%

6M

-31.23%

1Y

-15.77%

5Y*

13.77%

10Y*

5.28%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

VRTX vs. REGN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Vertex Pharmaceuticals Incorporated (VRTX) and Regeneron Pharmaceuticals, Inc. (REGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for VRTX, currently valued at 0.49, compared to the broader market-4.00-2.000.002.000.49-0.73
The chart of Sortino ratio for VRTX, currently valued at 0.79, compared to the broader market-4.00-2.000.002.004.000.79-0.86
The chart of Omega ratio for VRTX, currently valued at 1.10, compared to the broader market0.501.001.502.001.100.89
The chart of Calmar ratio for VRTX, currently valued at 0.79, compared to the broader market0.002.004.006.000.79-0.40
The chart of Martin ratio for VRTX, currently valued at 1.67, compared to the broader market0.0010.0020.001.67-1.10
VRTX
REGN

The current VRTX Sharpe Ratio is 0.49, which is higher than the REGN Sharpe Ratio of -0.73. The chart below compares the historical Sharpe Ratios of VRTX and REGN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
0.49
-0.73
VRTX
REGN

Dividends

VRTX vs. REGN - Dividend Comparison

Neither VRTX nor REGN has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

VRTX vs. REGN - Drawdown Comparison

The maximum VRTX drawdown since its inception was -91.77%, roughly equal to the maximum REGN drawdown of -91.81%. Use the drawdown chart below to compare losses from any high point for VRTX and REGN. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-13.40%
-40.54%
VRTX
REGN

Volatility

VRTX vs. REGN - Volatility Comparison

Vertex Pharmaceuticals Incorporated (VRTX) and Regeneron Pharmaceuticals, Inc. (REGN) have volatilities of 8.17% and 7.83%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%JulyAugustSeptemberOctoberNovemberDecember
8.17%
7.83%
VRTX
REGN

Financials

VRTX vs. REGN - Financials Comparison

This section allows you to compare key financial metrics between Vertex Pharmaceuticals Incorporated and Regeneron Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab